UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:May 11,
MyMD Pharmaceuticals (NASDAQ:MYMD)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more MyMD Pharmaceuticals Charts.
MyMD Pharmaceuticals (NASDAQ:MYMD)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more MyMD Pharmaceuticals Charts.

Mymd Pharmaceuticals, Inc. News

Form 8-K - Current report
Thursday 7 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
MyMD Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
Tuesday 5 March 2024 (2 months ago) • Business Wire
Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 13 February 2024 (3 months ago) • Edgar (US Regulatory)
MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
Tuesday 13 February 2024 (3 months ago) • Business Wire
Form 8-K - Current report
Wednesday 6 December 2023 (5 months ago) • Edgar (US Regulatory)
MyMD Pharmaceuticals Plans FDA-Cleared Phase 2 Clinical Trial of MYMD-1 in Rheumatoid Arthritis
Wednesday 6 December 2023 (5 months ago) • Business Wire
Form 8-K - Current report
Thursday 19 October 2023 (6 months ago) • Edgar (US Regulatory)
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain
Thursday 19 October 2023 (6 months ago) • Business Wire
Form 8-K - Current report
Friday 13 October 2023 (7 months ago) • Edgar (US Regulatory)

More Mymd Pharmaceuticals, Inc. News Articles